Comment on

• Should we biopsy each liver mass suspicious for hepatocellular carcinoma before liver transplantation?--yes.

  Marsh JW, Dvorchik I. Marsh JW, et al. J Hepatol. 2005 Oct;43(4):558-62. doi: 10.1016/j.jhep.2005.07.014. J Hepatol. 2005. PMID: 16112246 Review. No abstract available.
• Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation?--no, never.

  Hiatt JR, Carmody IC, Busuttil RW. Hiatt JR, et al. J Hepatol. 2005 Oct;43(4):573-7. doi: 10.1016/j.jhep.2005.07.017. J Hepatol. 2005. PMID: 16112768 Review. No abstract available.
• Is there a customised immunosuppressive regimen for patients transplanted with hepatocellular carcinoma?

  Majno P, Giostra E, Mentha G; Geneva Liver Cancer Study. Majno P, et al. J Hepatol. 2005 Oct;43(4):577-84. doi: 10.1016/j.jhep.2005.07.018. J Hepatol. 2005. PMID: 16118027 Review. No abstract available.
• How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?

  Schwartz M, Roayaie S, Llovet J. Schwartz M, et al. J Hepatol. 2005 Oct;43(4):584-9. doi: 10.1016/j.jhep.2005.07.019. J Hepatol. 2005. PMID: 16120468 Review. No abstract available.
• Should we biopsy each liver mass suspicious for HCC before liver transplantation?--no, please don't.

  Stigliano R, Burroughs AK. Stigliano R, et al. J Hepatol. 2005 Oct;43(4):563-8. doi: 10.1016/j.jhep.2005.07.015. J Hepatol. 2005. PMID: 16120469 Review. No abstract available.
• Should we expand the criteria for liver transplantation for hepatocellular carcinoma--yes, of course!

  Broelsch CE, Frilling A, Malago M. Broelsch CE, et al. J Hepatol. 2005 Oct;43(4):569-73. doi: 10.1016/j.jhep.2005.07.016. J Hepatol. 2005. PMID: 16120470 Review. No abstract available.